Meet Cromos™ Pharma’s VP, International Business & Operations, Dr. Gearóid Tuohy in Basel at the Swiss Biotech Day on 4 May and find out how Cromos™ Pharma can assist you in your clinical drug development programmes.
The Swiss Biotech Day is the leading biotechnology conference in Switzerland. This event will bring together more than 500 senior executives from the life science industry across Europe. Programme highlights in 2017 will include key notes from renowned industry experts, the presentation of the Swiss biotech report, and the annual general assembly of the Swiss Biotech Association.
If you plan to attend the conference or to be in Basel on this date, then feel free to set up a face to face meeting with Dr. Tuohy directly.
Cromos™ Pharma, LLC is a contract research organization (CRO) with operations in the post-Soviet space and in Eastern/Central Europe. The company provides a full spectrum of trial-related services which include clinical monitoring, regulatory approvals, medical writing, feasibility assessments, project management and warehousing. Cromos™ Pharma, LLC is a privately owned company.
Cromos Pharma is looking forward to taking part in the upcoming DIA Europe conference (15 – 19 March 2021). A highly collaborative event, it’s a great chance to meet with future partners and hear from innovators across the entire life sciences spectrum.
Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).